Back

NASDAQ Stock

Live symbol workspace

NASDAQ market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Status Chart ready
AI Accuracy on NASDAQ 40.9% (445 verified predictions)
View Leaderboard → View accuracy history →

Price Chart

📈
Loading chart for NASDAQ...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for NASDAQ skewed neutral (223 of 498 scored calls). The most accurate provider on this asset is groq-llama-3.1-8b-instant at 41.0% across 444 verified calls.

Provider track record

groq-llama-3.1-8b-instant
182/444 verified calls
41.0%

Confidence trend

60%
▲ 2.4 pts vs previous week
Avg confidence across 110 calls in the last 7 days

What sources say

Neutral 223 articles
Celularity Receives Nasdaq Notice Regarding Form 10-Q
Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing
Deep Sea Minerals Announces Application to List on the Nasdaq Capital Market; Shares up 12%
Bullish 206 articles
S&P 500, Nasdaq, Dow Jones Touch Record Highs as Trump Close to Making Decision on Iran Peace Deal
Hyperliquid Is 'Bigger Than Nasdaq,' Says ICE CEO — HYPE Eyes New Record High, While ETFs Top $100M
Dan Ives: Anthropic’s growth is 'just the tip of the sphere' for AI rally
Bearish 69 articles
THE GROWHUB LIMITED Announces Receipt of Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency
Peter Schiff: MicroStrategy’s ‘Smart’ Debt Buyback Just Torched 60% of Its Safety Net
Nasdaq and Dow Jones called lower as US and Iran exchange fire over Hormuz

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

NASDAQ News Intelligence (3593 articles)

AI-curated news influencing NASDAQ price, sentiment, and trend

Explore All NASDAQ News with AI Analysis
Economy
2 months, 4 weeks ago

Max Winner — Heard on the Street Friday Recap

Stocks sold off on the last trading day of February. Markets were spooked by a stronger-than-expected reading for producer-price inflation. …

Impact on NASDAQ: Market impact analysis based on bearish sentiment with 90% confidence.
The US stock market experienced a decline on the last trading day of February due … High (90%)
View full analysis →
Economy
2 months, 4 weeks ago

Aktsiaselts Infortar own share acquisition transactions

Aktsiaselts Infortar acquired its own shares on the Nasdaq Tallinn Stock Exchange during the period of 23 - 27 February …

Impact on NASDAQ: Market impact analysis based on neutral sentiment with 90% confidence.
Infortar acquired its own shares on the Nasdaq Tallinn Stock Exchange from February 23-27, 2026, … High (90%)
View full analysis →
Economy
2 months, 4 weeks ago

US futures and Asian shares open lower, oil prices soar as US and Israeli attack Iran

The U.S. and Israeli attacks on Iran rattled world markets early Monday, with U.S. futures falling more than 1% and …

Impact on NASDAQ: Market impact analysis based on bearish sentiment with 90% confidence.
US and Israeli attacks on Iran have caused a significant market downturn, with US futures … High (90%)
View full analysis →
Economy
3 months ago

Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?

Although Regeneron Pharmaceuticals has lagged the Nasdaq over the past year, analysts remain highly bullish about its prospects.

Impact on NASDAQ: Market impact analysis based on neutral sentiment with 60% confidence.
Regeneron Pharmaceuticals stock has underperformed the Nasdaq over the past year, but analysts are still … Medium (60%)
View full analysis →
Economy
3 months ago

Ocular Therapeutix (OCUL) Stock Trades Down, Here Is Why

Shares of ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) fell 8.6% in the afternoon session after a surprisingly hot wholesale inflation …

Impact on NASDAQ: Market impact analysis based on bearish sentiment with 90% confidence.
Ocular Therapeutix (OCUL) stock fell 8.6% due to investor concerns about persistent price pressures following … High (90%)
View full analysis →
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis